Engaging healthcare providers as research facilitators
Contrary to popular belief, the main reasons physicians are reluctant to refer patients to clinical trials have nothing to do with fear of losing them to other providers or a lack of knowledge about industry-sponsored clinical research. A new Tufts Center for the Study of Drug Development (CSDD) study found that healthcare providers (HCPs) have a higher-than-expected level of familiarity with clinical research and willingness to refer patients into trials. A significant majority of physicians also reported they are often the primary source of information about clinical trials for their patients and that they actively support their patients’ participation in research.
Acknowledging the dual enrollment challenge
When a sponsor or CRO is forced to throw out data or write off an entire study, millions of dollars are at stake. These are the high stakes that characterize the dual enrollment challenge. Enrolling just one ineligible subject already in a simultaneous study could cost a sponsor tens of thousands of dollars or more. When dual enrollment goes undetected and the entire study must be repeated, millions of dollars, and more importantly time, is wasted. Dual enrollment is often unmeasured and considered by many to be much less common than it once was. However, current data reveal it to be a very real risk that is still widespread.
To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.